Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for the most recent Alphatec Holdings insider trading Form 4 transactions or trying to decode an FDA comment buried deep in a 10-K? Investors often start with a single question—yet end up juggling hundreds of pages about spinal-implant clearances, surgeon partnerships, and R&D milestones. Our SEC filings hub puts every document in context, so you can focus on the implications for spinal-surgery innovation rather than on document hunting.
Each new Alphatec Holdings quarterly earnings report 10-Q filing arrives on Stock Titan within seconds of hitting EDGAR. AI then produces a concise Alphatec Holdings earnings report filing analysis, flags segment revenue shifts, and links directly to tables that matter to spine-device margins. Prefer real-time governance data? Alphatec Holdings Form 4 insider transactions real-time alerts track when surgeon-directors buy or sell shares—perfect for spotting confidence signals before product launches.
Need a high-level view? Start with Alphatec Holdings annual report 10-K simplified summaries that unpack R&D spend, FDA pathways, and competitive positioning. For event-driven traders, Alphatec Holdings 8-K material events explained highlights new product approvals and litigation updates within minutes. If compensation trends guide your valuation models, the Alphatec Holdings proxy statement executive compensation section is mapped to historical pay metrics. And if you just want the facts, "understanding Alphatec Holdings SEC documents with AI" quickly answers natural-language queries like “How much did R&D grow?” while “Alphatec Holdings SEC filings explained simply” gives plain-English context.
From compliance alerts to in-depth analysis, our platform turns Alphatec Holdings executive stock transactions Form 4 data and every other filing type into actionable spinal-tech insight—so you spend your time on decisions, not document searches.
Alphatec Holdings (ATEC) reported an insider transaction by its EVP, People & Culture. On 10/31/2025, the reporting person sold 100,000 shares of common stock in open-market trades at a weighted average price of $19.95, with individual transactions executed between $19.90 and $20.00. Following the sale, the insider beneficially owns 1,289,142 shares, held directly.
The filing notes the sales were made pursuant to a Rule 10b5‑1 trading plan adopted on March 5, 2025, which pre-schedules trades to reduce discretion by the insider.
Alphatec Holdings (ATEC) reported third-quarter results for the period ended September 30, 2025. Revenue from products and services was $196.5 million, up from $150.7 million a year ago. Gross profit was $137.3 million. Operating loss narrowed to $15.9 million from $33.7 million, while net loss was $28.6 million, or $0.19 per share, compared with $39.6 million, or $0.28 per share, last year.
For the first nine months of 2025, revenue reached $551.2 million versus $434.8 million in 2024. Net cash provided by operating activities was $24.5 million, a swing from $55.2 million used in the prior year period. Cash and cash equivalents were $155.7 million.
The company completed key financing actions: issued $405.0 million of 0.75% Senior Convertible Notes due 2030 (net proceeds ~$392.9 million), entered into $42.5 million capped call transactions, and repurchased 80% of its 0.75% Notes due 2026 for $268.4 million, recording a $17.6 million extinguishment loss. As of quarter-end, long-term debt (net of current portion) was $495.0 million, including a $200.0 million Braidwell term loan and $15.0 million outstanding on the revolving credit facility. Total stockholders’ equity improved to $11.5 million from a deficit at year-end 2024.
Alphatec Holdings, Inc. filed a Form 8‑K to furnish a press release announcing financial results for the period ended September 30, 2025. The disclosure is provided under Item 2.02.
The information, including Exhibit 99.1, is furnished and not filed and is not incorporated by reference. The company’s common stock (ticker ATEC) trades on the Nasdaq Global Select Market.
Alphatec Holdings (ATEC) reported an insider transaction: its EVP, Sales sold 70,000 shares of common stock on 10/24/2025 at a weighted average price of $16.18, executed under a Rule 10b5-1 trading plan adopted on June 12, 2025.
After the sale, the reporting person directly owned 461,861 shares. The sales occurred in multiple trades within a price range of $16.15 to $16.29.
Alphatec Holdings (ATEC) reported an insider transaction by its Chief Operating Officer. On 10/14/2025, the officer exercised employee stock options (code M) at $3.35 per share for 13,500 shares of common stock. Following the transaction, the officer beneficially owns 672,207 common shares directly.
The exercised option covered 13,500 underlying shares and carries an expiration date of 03/22/2028. According to the footnote, the grant vested 25% on March 22, 2019 and the remainder in 36 equal monthly installments.
Miles Patrick, who serves as CEO and a director of Alphatec Holdings, Inc. (ATEC), reported a sale of 100,000 shares of the company’s common stock on 10/01/2025 under a Rule 10b5-1 trading plan adopted June 3, 2025. The sales were executed at a weighted average price of $13.96, with individual sale prices ranging from $13.73 to $14.33. After the reported transactions, the filing shows Mr. Patrick beneficially owns 5,464,078 shares directly, plus 10,900 shares in an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 was signed on 10/02/2025 by an attorney-in-fact.
Alphatec Holdings, Inc. (ATEC) Form 144 shows a proposed sale of 300,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $4,362,000. The shares were originally acquired as restricted stock units on 10/02/2020. The filing lists total outstanding shares of 147,983,775 and an approximate planned sale date of 10/01/2025 on NASDAQ. The notice also discloses a related 10b5-1 sale on 09/02/2025 of 300,000 shares that generated gross proceeds of $4,717,830. The filer certifies they are not aware of any undisclosed material adverse information and references reliance on a trading plan or instruction where applicable.
David Sponsel, Executive Vice President, Sales of Alphatec Holdings, Inc. (ATEC), reported planned sales of common stock under a Rule 10b5-1 trading plan adopted June 12, 2025. The Form 4 shows sales on September 18, 2025 of 137,445 shares at an average price of $15.09 and on September 19, 2025 of 2,555 shares at a weighted average price of $15.34, leaving the reporting person with 531,861 shares beneficially owned after the transactions. The Form 4 was executed by an attorney-in-fact on the reporting dates and discloses that the September 19 price is a weighted average for multiple trades.
FAQ
What is the current stock price of Alphatec Hldgs (ATEC)?
What is the market cap of Alphatec Hldgs (ATEC)?
